AU2003215395A1 - STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS - Google Patents

STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS

Info

Publication number
AU2003215395A1
AU2003215395A1 AU2003215395A AU2003215395A AU2003215395A1 AU 2003215395 A1 AU2003215395 A1 AU 2003215395A1 AU 2003215395 A AU2003215395 A AU 2003215395A AU 2003215395 A AU2003215395 A AU 2003215395A AU 2003215395 A1 AU2003215395 A1 AU 2003215395A1
Authority
AU
Australia
Prior art keywords
meningoccocal
immunogens
hbc chimer
chimer particles
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215395A
Other versions
AU2003215395A8 (en
Inventor
Ashley J. Birkett
Birgit Peck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apovia Inc
Original Assignee
Apovia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apovia Inc filed Critical Apovia Inc
Publication of AU2003215395A8 publication Critical patent/AU2003215395A8/en
Publication of AU2003215395A1 publication Critical patent/AU2003215395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003215395A 2002-02-21 2003-02-21 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS Abandoned AU2003215395A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35861802P 2002-02-21 2002-02-21
US60/358,618 2002-02-21
PCT/US2003/005499 WO2003072731A2 (en) 2002-02-21 2003-02-21 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS

Publications (2)

Publication Number Publication Date
AU2003215395A8 AU2003215395A8 (en) 2003-09-09
AU2003215395A1 true AU2003215395A1 (en) 2003-09-09

Family

ID=27765969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215395A Abandoned AU2003215395A1 (en) 2002-02-21 2003-02-21 STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS

Country Status (2)

Country Link
AU (1) AU2003215395A1 (en)
WO (1) WO2003072731A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2709176T3 (en) 2006-08-11 2019-04-15 Life Sciences Res Partners Vzw Immunogenic peptides and their use in immune disorders
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
ES2545886T3 (en) 2008-02-14 2015-09-16 Life Sciences Research Partners Vzw Immunotherapy for intracellular pathogens
AU2009214039B2 (en) 2008-02-14 2013-09-19 Katholieke Universiteit Leuven Immunogenic control of tumours and tumour cells
JP5667062B2 (en) 2008-10-10 2015-02-12 エラ、ビオテック、ソシエダッド、アノニマＥｒａ Ｂｉｏｔｅｃｈ， Ｓ．Ａ． Recombinant protein granules as immunogen-specific adjuvants
EP2418284A1 (en) 2010-08-13 2012-02-15 ERA Biotech, S.A. Protein body-inducing polypeptide sequences
BR112013012555B8 (en) 2010-11-25 2022-09-06 Imnate Sarl ISOLATED IMMUNOGENIC PEPTIDE DERIVED FROM AN ANTIGEN PROTEIN, ITS USES, METHOD FOR THE PREPARATION OF A PEPTIDE WITH THE CAPACITY OF PROVOKING THE ACTIVATION OF NKT CELLS AND IN VITRO METHOD FOR OBTAINING A SPECIFIC ANTIGEN CD4+ NKT CELL POPULATION
GB201201511D0 (en) * 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
CA2995771A1 (en) 2015-09-25 2017-03-30 Imcyse Sa Improved methods and compounds for eliminating immune responses to therapeutic agents
BR112018071466A2 (en) 2016-04-19 2019-03-19 Imcyse Sa new immunogenic cd1d binding peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
EP1054689B1 (en) * 1998-02-12 2003-09-10 Immune Complex, Corporation Strategically modified hepatitis b core proteins and their derivatives
EP1294893B1 (en) * 2000-06-22 2006-03-15 UCB Pharma Limited Modification of hepatitis b core antigen

Also Published As

Publication number Publication date
WO2003072731A2 (en) 2003-09-04
AU2003215395A8 (en) 2003-09-09
WO2003072731A3 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
AU2003247718A1 (en) Advanced thermoplastics for orthodontics
AU2003293294A1 (en) Uv-stabilised particles
AU2003280680A1 (en) Xanthine compound
AU2003267164A1 (en) Retrievable filter
AU2003221399A1 (en) Filter
AU2003235475A1 (en) Filter assembly
AU2003261987A1 (en) Spotlight
AU2003225901A1 (en) Stabilized inorganic particles
AU2003245800A1 (en) Flavourant compounds
AU2003215395A1 (en) STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS
GB2391174B (en) Particle formation
AU2003201888A1 (en) Resin particles
AU2003213168A1 (en) IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
AU2003244440A1 (en) Method for producing granulates
AU2003297388A1 (en) Candle melting system
AU2003270268A1 (en) Filter holder
AU2003242270A1 (en) Process for producing pyrimidine compound
AU2003295469A1 (en) Process for producing carbonaceous materials
AU2003287174A1 (en) Process for synthesizing antifolates
AU2002360569A1 (en) Parts feeder
AU2003210077A1 (en) Process for small particle formation
AU2003220912A1 (en) Processes for producing indole compound
AU2003282501A1 (en) Three component filtration material
AU2003213194A1 (en) IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
AU2003213252A1 (en) Modified bace

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase